0

Close
 
Upcoming Allied Market Research
2023
Cardiac Catheters And Guidewires Market

Cardiac Catheters and Guidewires Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

LS : Medical Devices & Supplies
Report Code: A10387
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cardiac Catheters And Guidewires Market

Request Now !

Cardiac catheters is device which is widely used in cardiac catheterization, angioplasty, Percutaneous Coronary Intervention (PCI), and other interventional procedures. In the cardiac catheter helps to measuring heart muscle function and also identify the presence of valve disease and coronary artery disease. Cardiac catheter is the initial step for procedures like angioplasty and other interventional procedures. For the treatment of such diseases insertion of the Cardiac catheters and guidewires are commonly used. Catheter-based interventional procedure used for the treatment of coronary artery disease. In this procedure, cardiac catheter is used for opening the blockage of coronary arteries, which rises the blood flow to the heart. Similarly, for the treatment of peripheral vascular diseases angioplasty is mostly recommended by physicians. In this procedure, the cardiac catheter is inserted through the blood vessel to examine the affected artery, which then reopens the artery and flattens the blockage of the artery wall. 

Generally cardiac disorder caused by the diabetes. There are two types of diabetes are occur i.e.,  Type I and Type II out of these Type II diabetes is the most common and around 90.00% of diabetes cases are type II diabetes occurring across the globe. Heart diseases and stroke are caused due to type II diabetes. In 2019, “International Diabetes Federation”, reported that the around 463.0 million adults were suffering from diabetes and 1.1.million adolescents and children suffered from type I diabetes across the globe. Furthermore, adoption of unhealthy lifestyles, such as smoking, physical inactivity, and improper diet, is responsible for diabetes. Cardiac catheterization, angioplasty, and Percutaneous Coronary Intervention (PCI) are some of the major procedures used for the treatment of cardiovascular disease which rises the demand for Cardiac catheters and guidewires procedures. 

COVID-19 Scenario Analysis:

To take care of infected population the demand for medical supplies is increasing. Respiratory support devices such as atomizer, life-support machine, oxygen generator, and monitor are among the majorly used medical devices in primary clinical treatment. Moreover, COVID-19 has led to a huge surge in demand for medical supplies such as personal protective equipment including masks, gloves, and protective eyeglasses. With rise in number of COVID-19 cases worldwide, the need for medical supplies keeps on rising among, both from healthcare professionals and civil population for precautionary measures. Manufacturers of these products have a chance to capitalize this increased demand of medical supplies to ensure adequate andcontinuous supply of personal protective equipment in the market. 

The ongoing outbreak of COVID-19 pandemic, affects the cardiac catheters & guidewires market adversely. Due to the temporarily shutting down of industries major market manufacturer and hospitals are losses their business. It affect the supply chain the product and patient also not getting proper treatment. These problem affect the demand which reduces continuously which may hamper the cardiac catheters & guidewires market growth

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis:

Globally, North America dominated the overall cardiac catheters and guidewires market due to the presence of favourable compensation policies, availability of technologically advanced products, and presence of major market players. However, Asia-Pacific is expected to contribute largest growth rate due to the rising geriatric population, increasing incidence of cardiovascular diseases and diabetes and increasing demand for surgeries.  

In 2019, “American Hospital Association”, reported that, around 6,210 hospitals were reported in U.S. out of which 2,968 are nongovernment not-for-profit community hospitals and 972 are state and local government community hospitals. In 2018, “World Heart Federation”, reported that 80.0% of the deaths in developing region are caused due to cardiovascular diseases and around 17.9 million deaths occur globally due to CVDs. the demand for cardiac catheterization, angioplasty, and other interventional procedures, which, in turn, will raise the demand for cardiac catheters. In 2018 “Centers for Disease Control & Prevention (CDC), reported that around 370,000 people die every year in U.S, due to the coronary heart disease is the most common type of cardiovascular disease and around 735,000 Americans to have a heart attack every year. 

The major driving factor that drive the cardiac catheters & guidewires market such as rising demand for minimally invasive procedures, growing ambulatory surgical  and hospitals across the globe, growing prevalence of diabetes which increased cardiovascular diseases, increasing government initiatives, increasing geriatric population, etc. However, factors such as high cost of treatment, lack of experienced professionals, low adoption of advanced healthcare facilities, lack of awareness among people regarding the treatment of cardiac diseases and low healthcare reimbursement facilities in the developing countries, are restraining growth of the global cardiac guidewires market.  The opportunity available for cardiac catheters & guidewires market is developing innovative new products with focus on patient’s comfort and increasing geriatric population. 

New product launches to flourish the market:

Manufacturers have been focusing on producing new products for specific applications as there are varying demands based on the utilization. Leading market players have determined how improved accuracy can be influential in many applications. In 2018, “Boston Scientific Corporation” has launched “iCross Coronary Imaging Catheter”. This cardiac catheter is help to improve the intravascular ultrasound (IVUS) technology. In 2019, “Abbott” has launched “HD grid mapping catheter” in India which help in improving complex cardiac ablation procedure. In 2019, “Getting AB” has launched newest catheter such as “Sensation plus”. This device utilizes the benefits of fiber-optic technology. These benefits translate to faster initiation of therapy, easier patient management, crisp, clean arterial pressure waveform and automatic in vivo calibration.

Key benefits of the report:

  • This study presents the analytical depiction of the global cardiac catheters & guidewires market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the cardiac catheters & guidewires market share.
  • The current market is quantitatively analyzed to highlight the global cardiac catheters & guidewires market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global cardiac catheters & guidewires market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions answered in the Trauma Care Centers Market research report:

  • Who are the leading market players active in the cardiac catheters & guidewires market?
  • What are the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that will help in taking further strategic steps?

 Cardiac Catheters and Guidewires Market: Global Opportunity Analysis and Industry Forecast, 2020–2027 Report Highlights

Aspects Details
By Product
  • Cardiac Catheters
  • Cardiac Guidewires
By End User
  • Hospitals
  • Clinics
  • Ambulatory Surgery Centers (ASCs)
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Biotronik SE & Co. KG, St. Jude Medical Inc., Getinge AB, Medtronic, Inc., Cordis, Biosense Webster, QXMédical, Boston Scientific Corporation, Terumo Medical Corporation, Teleflex Incorporated, Abbott
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: CARDIAC CATHETERS AND GUIDEWIRES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Cardiac Catheters

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Cardiac Guidewires

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: CARDIAC CATHETERS AND GUIDEWIRES MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ambulatory Surgery Centers (ASCs)

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: CARDIAC CATHETERS AND GUIDEWIRES MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Cardiac Catheters And Guidewires Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Cardiac Catheters And Guidewires Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Cardiac Catheters And Guidewires Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Cardiac Catheters And Guidewires Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Cardiac Catheters And Guidewires Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Cardiac Catheters And Guidewires Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Cardiac Catheters And Guidewires Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Cardiac Catheters And Guidewires Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Cardiac Catheters And Guidewires Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Cardiac Catheters And Guidewires Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Cardiac Catheters And Guidewires Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Cardiac Catheters And Guidewires Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Cardiac Catheters And Guidewires Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Cardiac Catheters And Guidewires Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Cardiac Catheters And Guidewires Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Cardiac Catheters And Guidewires Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Cardiac Catheters And Guidewires Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Cardiac Catheters And Guidewires Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Cardiac Catheters And Guidewires Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Cardiac Catheters And Guidewires Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Cardiac Catheters And Guidewires Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Cardiac Catheters And Guidewires Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Cardiac Catheters And Guidewires Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Cardiac Catheters And Guidewires Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Cardiac Catheters And Guidewires Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning,2022

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Abbott

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Boston Scientific Corporation

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. Getinge AB

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Terumo Medical Corporation

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Medtronic

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. Biotronik SE And Co. KG

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Biosense Webster

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Inc., Cordis

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. QXMédical

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Teleflex Incorporated

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

    • 8.11. St. Jude Medical Inc.

      • 8.11.1. Company Overview

      • 8.11.2. Key Executives

      • 8.11.3. Company Snapshot

      • 8.11.4. Operating Business Segments

      • 8.11.5. Product Portfolio

      • 8.11.6. Business Performance

      • 8.11.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR CARDIAC CATHETERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR CARDIAC GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR CLINICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR AMBULATORY SURGERY CENTERS (ASCS), BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. NORTH AMERICA CARDIAC CATHETERS AND GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. NORTH AMERICA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 11. NORTH AMERICA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 12. U.S. CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 13. U.S. CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 14. CANADA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 15. CANADA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. MEXICO CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 17. MEXICO CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 18. EUROPE CARDIAC CATHETERS AND GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. EUROPE CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 20. EUROPE CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. FRANCE CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. FRANCE CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. GERMANY CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. GERMANY CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 25. ITALY CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. ITALY CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. SPAIN CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. SPAIN CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. UK CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. UK CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 31. RUSSIA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. RUSSIA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. REST OF EUROPE CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. REST OF EUROPE CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 35. ASIA-PACIFIC CARDIAC CATHETERS AND GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 36. ASIA-PACIFIC CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. ASIA-PACIFIC CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. CHINA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. CHINA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. JAPAN CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 41. JAPAN CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. INDIA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. INDIA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 44. SOUTH KOREA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 45. SOUTH KOREA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. AUSTRALIA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 47. AUSTRALIA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. THAILAND CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. THAILAND CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 50. MALAYSIA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 51. MALAYSIA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. INDONESIA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. INDONESIA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. LAMEA CARDIAC CATHETERS AND GUIDEWIRES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 57. LAMEA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 58. LAMEA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. BRAZIL CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. BRAZIL CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. SOUTH AFRICA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. SOUTH AFRICA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. SAUDI ARABIA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. SAUDI ARABIA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. UAE CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 66. UAE CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. ARGENTINA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. ARGENTINA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 69. REST OF LAMEA CARDIAC CATHETERS AND GUIDEWIRES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. REST OF LAMEA CARDIAC CATHETERS AND GUIDEWIRES, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. ABBOTT: KEY EXECUTIVES
  • TABLE 72. ABBOTT: COMPANY SNAPSHOT
  • TABLE 73. ABBOTT: OPERATING SEGMENTS
  • TABLE 74. ABBOTT: PRODUCT PORTFOLIO
  • TABLE 75. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
  • TABLE 77. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 78. BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 79. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 80. BOSTON SCIENTIFIC CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. GETINGE AB: KEY EXECUTIVES
  • TABLE 82. GETINGE AB: COMPANY SNAPSHOT
  • TABLE 83. GETINGE AB: OPERATING SEGMENTS
  • TABLE 84. GETINGE AB: PRODUCT PORTFOLIO
  • TABLE 85. GETINGE AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. TERUMO MEDICAL CORPORATION: KEY EXECUTIVES
  • TABLE 87. TERUMO MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 88. TERUMO MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 89. TERUMO MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 90. TERUMO MEDICAL CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. MEDTRONIC: KEY EXECUTIVES
  • TABLE 92. MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 93. MEDTRONIC: OPERATING SEGMENTS
  • TABLE 94. MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 95. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. BIOTRONIK SE AND CO. KG: KEY EXECUTIVES
  • TABLE 97. BIOTRONIK SE AND CO. KG: COMPANY SNAPSHOT
  • TABLE 98. BIOTRONIK SE AND CO. KG: OPERATING SEGMENTS
  • TABLE 99. BIOTRONIK SE AND CO. KG: PRODUCT PORTFOLIO
  • TABLE 100. BIOTRONIK SE AND CO. KG: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. BIOSENSE WEBSTER: KEY EXECUTIVES
  • TABLE 102. BIOSENSE WEBSTER: COMPANY SNAPSHOT
  • TABLE 103. BIOSENSE WEBSTER: OPERATING SEGMENTS
  • TABLE 104. BIOSENSE WEBSTER: PRODUCT PORTFOLIO
  • TABLE 105. BIOSENSE WEBSTER: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. INC., CORDIS: KEY EXECUTIVES
  • TABLE 107. INC., CORDIS: COMPANY SNAPSHOT
  • TABLE 108. INC., CORDIS: OPERATING SEGMENTS
  • TABLE 109. INC., CORDIS: PRODUCT PORTFOLIO
  • TABLE 110. INC., CORDIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. QXMéDICAL: KEY EXECUTIVES
  • TABLE 112. QXMéDICAL: COMPANY SNAPSHOT
  • TABLE 113. QXMéDICAL: OPERATING SEGMENTS
  • TABLE 114. QXMéDICAL: PRODUCT PORTFOLIO
  • TABLE 115. QXMéDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. TELEFLEX INCORPORATED: KEY EXECUTIVES
  • TABLE 117. TELEFLEX INCORPORATED: COMPANY SNAPSHOT
  • TABLE 118. TELEFLEX INCORPORATED: OPERATING SEGMENTS
  • TABLE 119. TELEFLEX INCORPORATED: PRODUCT PORTFOLIO
  • TABLE 120. TELEFLEX INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 121. ST. JUDE MEDICAL INC.: KEY EXECUTIVES
  • TABLE 122. ST. JUDE MEDICAL INC.: COMPANY SNAPSHOT
  • TABLE 123. ST. JUDE MEDICAL INC.: OPERATING SEGMENTS
  • TABLE 124. ST. JUDE MEDICAL INC.: PRODUCT PORTFOLIO
  • TABLE 125. ST. JUDE MEDICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CARDIAC CATHETERS AND GUIDEWIRES MARKET
  • FIGURE 3. SEGMENTATION CARDIAC CATHETERS AND GUIDEWIRES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CARDIAC CATHETERS AND GUIDEWIRES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCARDIAC CATHETERS AND GUIDEWIRES MARKET
  • FIGURE 11. CARDIAC CATHETERS AND GUIDEWIRES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR CARDIAC CATHETERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR CARDIAC GUIDEWIRES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. CARDIAC CATHETERS AND GUIDEWIRES MARKET SEGMENTATION, BY BY END USER
  • FIGURE 15. CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR CLINICS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. CARDIAC CATHETERS AND GUIDEWIRES MARKET FOR AMBULATORY SURGERY CENTERS (ASCS), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: CARDIAC CATHETERS AND GUIDEWIRES MARKET
  • FIGURE 24. Top player positioning, 2022
  • FIGURE 25. ABBOTT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 26. ABBOTT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 27. ABBOTT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 28. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 29. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 30. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 31. GETINGE AB: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 32. GETINGE AB: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 33. GETINGE AB: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 34. TERUMO MEDICAL CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 35. TERUMO MEDICAL CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 36. TERUMO MEDICAL CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 37. MEDTRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. MEDTRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. BIOTRONIK SE AND CO. KG: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. BIOTRONIK SE AND CO. KG: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. BIOSENSE WEBSTER: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. BIOSENSE WEBSTER: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. BIOSENSE WEBSTER: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. INC., CORDIS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. INC., CORDIS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. INC., CORDIS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. QXMéDICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. QXMéDICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. QXMéDICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. TELEFLEX INCORPORATED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. TELEFLEX INCORPORATED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. TELEFLEX INCORPORATED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. ST. JUDE MEDICAL INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. ST. JUDE MEDICAL INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. ST. JUDE MEDICAL INC.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Cardiac Catheters And Guidewires Market

Start reading.
This Report and over 66,983+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers